Invitae
NVTA
$0.01950
Share price
0.00%
Change (1 day)
-98.61%
Change (1 year)
Invitae (NVTA) - Cash on Hand
Cash on Hand as of September 2023 : $0.25 B
According to Invitae
's latest financial reports the company has $0.25 B in cash and cash equivalents.
A company’s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.
Invitae - Cash on Hand chart (from 2013 to 2023)
Cash on Hand by year
| Year | Cash on Hand | Change |
|---|---|---|
| 2022-12-31 | $0.54 B | -47.66% |
| 2021-12-31 | $1.04 B | 195.32% |
| 2020-12-31 | $0.35 B | -9.66% |
| 2019-12-31 | $0.39 B | 211.26% |
| 2018-12-31 | $0.12 B | 94.69% |
| 2017-12-31 | $64.66 M | -30.19% |
| 2016-12-31 | $92.62 M | -27.08% |
| 2015-12-31 | $0.12 B | 18.68% |
| 2014-12-31 | $0.10 B | 148.5% |
| 2013-12-31 | $43.07 M | 97.56% |
| 2012-12-31 | $21.8 M |
Cash on Hand for similar companies or competitors
| Company | Cash on Hand | differencediff. | Country |
|---|---|---|---|
 Celldex Therapeutics CLDX | $0.42 B | 66.40% | 🇺🇸 USA |
 HTG Molecular Diagnostics
HTGM | $6.56 M | -97.42% | 🇺🇸 USA |
 CareDx CDNA | $0.23 B | -7.52% | 🇺🇸 USA |